Inovio Pharmaceuticals Ownership | Who Owns Inovio Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Inovio Pharmaceuticals Ownership Summary


Inovio Pharmaceuticals is owned by 26.19% institutional investors, 0.51% insiders, and 73.30% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 5.10% of INO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Inovio Pharmaceuticals shares.

INO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInovio Pharmaceuticals26.19%0.51%73.30%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deep track capital, lp1.98M5.10%$4.03M
Blackrock funding, inc. /de537.63K1.38%$1.09M
Gmt capital126.12K0.32%$256.65K
Qube research115.16K0.30%$234.36K
Cibc private wealth group80.00K0.21%$162.80K
Hrt financial lp72.22K0.19%$146.00K
Green alpha advisors53.31K0.14%$108.48K
American century companies42.92K0.11%$87.34K
Y-intercept (hong kong)42.17K0.11%$85.82K
Two sigma securities23.00K0.06%$46.81K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Deep track capital, lp1.98M0.13%$4.03M
Green alpha advisors53.31K0.10%$108.48K
Gmt capital126.12K0.01%$256.65K
Point72 asia (singapore) pte.17.89K0.01%$36.40K
Two sigma securities23.00K0.01%$46.81K
Eqis capital management16.39K0.00%$33.35K
Covestor1.86K0.00%$4.00K
Y-intercept (hong kong)42.17K0.00%$85.82K
Xtx topco22.04K0.00%$44.85K
Keystone financial group10.07K0.00%$20.50K

Top Buyers

HolderShares% AssetsChange
Qube research115.16K0.00%115.16K
Hrt financial lp72.22K0.00%72.22K
Y-intercept (hong kong)42.17K0.00%42.17K
Cibc private wealth group80.00K0.00%40.00K
Two sigma securities23.00K0.01%23.00K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de537.63K--1.78M
Deep track capital, lp1.98M0.13%-1.14M
Aigh capital management---654.12K
Stonepine capital management---518.33K
Highbridge capital management---300.00K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp72.22K0.00%72.22K$146.00K
Y-intercept (hong kong)42.17K0.00%42.17K$85.82K
Two sigma securities23.00K0.01%23.00K$46.81K
Point72 asia (singapore) pte.17.89K0.01%17.89K$36.40K
Raymond james financial371.00-371.00$755.00

Sold Out

HolderChange
Sachetta-3.00
Cbiz investment advisory services-4.00
Strategic investment solutions, inc. /il-16.00
Rothschild investment-60.00
Ifp advisors-175.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025106-1.85%10,167,785-25.24%262.11%47-9.62%293.57%
Mar 31, 20251081.89%13,600,9321.91%351.57%53-8.62%2780.00%
Dec 31, 20241063.92%13,346,63655.81%475.12%5826.09%15-28.57%
Sep 30, 2024102-8,566,0456.31%303.47%46-13.21%21-
Jun 30, 202410210.87%8,057,46098.11%299.72%5360.61%21-62.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.60M3.14%470.46K
Vanguard US Total Market Shares ETF818.82K2.23%-
iShares Russell 2000 Value ETF324.75K0.89%-
Fidelity Small Cap Index377.40K0.74%-15.86K
Vanguard Institutional Extnd Mkt Idx Tr375.64K0.74%-171.17K
Vanguard Russell 2000 ETF180.62K0.49%1.64K
Vanguard Strategic Equity Inv250.14K0.49%-
State St Russell Sm/Mid Cp® Indx NL Cl C150.74K0.41%-
State St Russell Sm/Mid Cp® Indx SL Cl I150.74K0.41%-
Fidelity Extended Market Index196.91K0.39%-514.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2023Zoth Lota S.-Sell$3.19K
Mar 13, 2023Weiner David B.-Sell$6.71K
Feb 27, 2023Weiner David B.-Sell$14.94K
Aug 11, 2022Weiner David B. Sell$31.59K
Jul 20, 2022BENITO SIMON X Sell$4.50K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

INO Ownership FAQ


Who Owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals shareholders are primarily institutional investors at 26.19%, followed by 0.51% insiders and 73.30% retail investors. The average institutional ownership in Inovio Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Inovio Pharmaceuticals falls below.

Who owns the most shares of Inovio Pharmaceuticals?

Inovio Pharmaceuticals’s largest shareholders are Deep track capital, lp (1.98M shares, 5.10%), Blackrock funding, inc. /de (537.63K shares, 1.38%), and Gmt capital (126.12K shares, 0.32%). Together, they hold 6.81% of Inovio Pharmaceuticals’s total shares outstanding.

Does Blackrock own Inovio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Inovio Pharmaceuticals.

Who is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Deep track capital, lp is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 1.98M Inovio Pharmaceuticals shares, valued at 4.03M$.

Who is the top mutual fund holder of Inovio Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inovio Pharmaceuticals shares, with 3.14% of its total shares outstanding invested in 1.6M Inovio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools